ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FAB Fusion Antibodies Plc

3.40
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.40 3.30 3.50 3.40 3.40 3.40 78,622 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.25 3.24M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.40p. Over the last year, Fusion Antibodies shares have traded in a share price range of 2.90p to 9.375p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.24 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.25.

Fusion Antibodies Share Discussion Threads

Showing 3876 to 3899 of 4200 messages
Chat Pages: Latest  156  155  154  153  152  151  150  149  148  147  146  145  Older
DateSubjectAuthorDiscuss
29/12/2023
15:15
2 decent buys at the end today Hopefully the share of 2024
bigjock36
26/12/2023
21:28
hxxps://youtu.be/8y_ZZiRbP2k?feature=shared

Watch the investor presentation where CEO talks around this.

The NCI partnership is cash neutral but fusion have agreed NCI can retain the antibodies they are targeting.

Key thing is the company have agreed the limited set with the NCI, they can also work on these with clients and they are happy they have not lost anything.

The key thing for the company is the validation by the world leading research agency of their world first prototype technology. Aka if they are succcessul then the technology is proven at zero cost to fusion and will be highly attractive in the market and likely that NCI will wish to continue to use on a fee for use basis(or buyout) on the other side

gtc1508
23/12/2023
12:33
A date for your diaries and a chance to meet the company management if you in or around the London area on January 11th:
timbo003
23/12/2023
12:17
Anyone here with solid research can you tell me in layman's terms in relation to the NCI collaboration what they mean by the statement:-

“The validation will be run at NCI's laboratories by their staff and antibodies identified pursuant to the Agreement would be retained by NCI”

So are they saying, here is our catalogue of antibodies, take your pick, NCI then spend a couple of years R&D on them against diseases they are working on finding cures for, NCI if it goes well find that antibody 1234 is effective against X and on result, it validates that FAB have a useful catalogue of antibodies but the antibody 1234 that works in this example is retained by NCI for drug dev to commercialisation?

I’m struggling to work out how FAB would financially benefit here in the event of success? If this was a license deal they would get milestone payments? In this example it looks like NCI get the catalogue for nothing but obviously have cost to R&D with it but it’s retained by NCI on success ???

Anyone care to enlighten me what I’m missing here?

porky9
15/12/2023
15:31
Moving up nicely, even on small. A bit of bigness will see it shift quite a way higher.

f

fillipe
13/12/2023
10:54
Broker note published todayToday 10:46


Cash runway until at least middle of 2024 - predictions that will be cash flow breakeven at this point.

Continuing month on month sales increase - confirms trend continuing in October.

AI/ML partnership shortly.

Stronger signs Biotech bear market coming to an end.

gtc1508
13/12/2023
04:40
There will be No placing.
daniel
12/12/2023
10:02
Definitely be a placing, however the company will try and hold off until it gets a contract and a spike in share price
wj12
11/12/2023
12:52
What price will placing be?
darkhearse
11/12/2023
12:34
And down she goes again . Not looking very good for the rampers.
Unfortunately when funding is a major concern shares will drop until finances are sorted .

bones698
08/12/2023
10:49
Well FAB is all paid for, and not on leverage. I will take my chances here in riding them out. In the meantime a share that you will love is My Health Checked. They have 5m in the bank adding interest and a huge range of Covid products that are sold in boots and on Amazon etc. I think MHC is the safest share I hold.
luckyabbeygale
08/12/2023
10:46
Last week I sold ENET at 200 profit at 1.5p. Only hours later I could of had 600 more profit if I sold at 1.95p, and now they are 1.2p to sell. Same with Future metals two weeks ago. I sold at 2.8p and made 250 profit and then they went to 3.3p to sell and now just 1.5p. Therefore I understand what you mean about GDR. I have a talent at spotting them but bad timing as a trader.
luckyabbeygale
08/12/2023
10:37
luckyabbeygale,

Look back at the chart for FAB.

Can you see that massive fall in the share price in May? From c. 40p to about 6p?

That coincided with this RNS when the 5p placing was announced:



It's unlikely that the next placing will have such a huge discount. But it's also unlikely that FAB will make it through 2024 without yet another placing. If you disagree then buy, it's your choice and the decision is solely down to you.

JakNife

jaknife
08/12/2023
10:29
What about POLX since some traders refused to buy in after a great rns at 5.5p yesterday, because they need to raise funds. I bought at 5.5p and sold too soon at 7p and now they are 8p to sell and rising. These placing fears have cost me a lot more profit in both GDR and in POLX. Why should I make the same mistake again in FAB?.
luckyabbeygale
08/12/2023
10:06
luckyabbeygale,

Well done on making a quick profit on a scalp trade.

You appear to be referring to this post:



==================================
luckyabbeygale,

"I missed the rise and was worried the sells start coming again. Therefore I only bought 200 pp at 6p and now I wish I bought a lot more."

You'll get the chance to buy a lot more at a lot lower, the accounts note that they expect to place in Q1.

JakNife
==================================

This comment was based on the words in GDR's accounts:

"The Group and Company does not currently have sufficient cash resources to continue as a going concern during the forecast period due to the time expected to be needed to gain commercial traction in its revenues. Therefore, the Company will need to raise further equity, or other funding, in early 2024 in order to continue as a going concern. The forecasts prepared by the Directors include a plan to raise additional funds from equity investors or debt providers in early 2024 to allow the Company to continue as a going concern." [my bold]

see:

Q1 is a period of time that starts on 1 Jan 2024 and ends on 31 March 2024. I will entertain complaints about my post above at the end of Q1. In the meantime I wish you a joyous Christmas!

JakNife

jaknife
08/12/2023
09:48
JakNife you told me GDR will be a lot cheaper soon due to a placing. I bought at 6p and I sold at 6.75p. Now they are 9p to sell. Lesson learnt that FAB will be doing a Gene Drive and putting them placing idiots to rest.
luckyabbeygale
08/12/2023
01:28
Boiler room bunnies are hammering away lol
bobaxe1
07/12/2023
18:26
It's better to stay with the FAB's board that said the fund is enough to carry them through to BE. They certainly know more than you guys, and should have learnt their lessons. When the news of another deal hits the market, it could quadruple the share price in a day.
You never anticipated the NCI deal, likewise you don't know what's coming next.

daniel
07/12/2023
13:19
I suggest that they may never be able to raise again. When the pot dry's up, someone might pick up the dregs on the cheap - maybe Paul Warwick will be able it make an offer if he has some spare cash to pick the whole thing up, so he gets anther shot at it.
clocktower
07/12/2023
13:04
Must admit unless they manage to sign some decent deals they will be raising cash in the next few months for sure . Even with a big contract which hasn't arrived and is never guaranteed until it's signed the cash position is precarious and the longer they leave it and closer they get to running out of cash the worse the raise will be for investors ..
The mkt cap is minimal just over a million leaks anything decent could see this rocket but the odds of that are slim and it's this price for a reason.
I'll wait for news and financing before even thinking of investing here it's just very very high risk

bones698
06/12/2023
17:25
Jak the Jackal, the lone wolf; always looking for sheep to carry to his handlers.
I knew you from the late 90s and early 20s. You need to change your ways, stop misusing your forensic accounting experiences and invest in dividend-paying FTSE 100 companies. Good luck and happy Christmas

daniel
06/12/2023
17:18
LOL daniel - his warnings were spot on when the nasty Paul Warwick was trying desperately to shore up his position by ramping this and saying he was getting his friends to buy even when it bounced to 95p, as I think he must have swallowed hook sink and line what the previous Board of Directors feed him.

I never like to see Private Investors make losses but in his case I have no sympathy at all, due to his actions.

I have not followed it closely since they did the raise at the huge discount after the first profitable bounce, while warning this share is a dog.

Still if you to have taken the bait, I hope you will not get hurt if and when the hook bites.

clocktower
06/12/2023
16:54
daniel,

You most certainly don't know me, back in 3676 you posted:

"He works for certain brokerage firms seeking to undermine companies by depressing the share prices; in the hope of getting cheap shares after front-selling. Check out his history with many companies. He is a scammer that manipulates unseasoned PI's."

Which was a slur that you made up.

FWIW I've spent the last 30 years of my working history being an actuary, an investment banker and then Chief Financial Officer of a small software business. I have now retired.

And this evening I am now going to retire for Christmas dinner with my favourite broker in the Long Room.
If anyone else is going please come and find me on Sara's table!

JakNife

jaknife
06/12/2023
16:34
Clocktower, you don't know Jak and his handlers. I have known him for 20 years. There is no fact in what he says, it's twisted
daniel
Chat Pages: Latest  156  155  154  153  152  151  150  149  148  147  146  145  Older

Your Recent History

Delayed Upgrade Clock